A multidisciplinary group of physicians, nurses, pharmacists and patients teamed up to provide guidelines on how many opioid painkillers should be prescribed following specific procedures.
Researchers at the University of British Columbia have developed a “smart stent” that can monitor hemodynamic changes in the artery and warn clinicians of restenosis at its earliest stages.
Providers were just as likely to perform low-value coronary revascularizations after joining an accountable care organization (ACO), a new analysis found. Considering ACOs are designed to curb healthcare spending, these findings suggest their current setup doesn’t properly incentivize specialists to change their behavior.
Coronary artery bypass graft (CABG) surgeries, in particular, were strongly linked to the life-threatening condition—carrying a 14-fold increase in relative risk, among the top five of all inpatient procedures analyzed.
Jun 12, 2018 | Imaging
A noninvasive imaging technique combined with fractional flow reserve (FFR) showed the potential to detect functionally significant lesions in patients with multivessel coronary artery disease (CAD), according to a study published June 11 in the Journal of the American College of Cardiology.
The introduction of high-sensitivity cardiac troponin T (hs-cTnT) in Sweden was associated with an 11 percent reduction in reinfarctions among heart attack patients and increased use of coronary angiography and revascularization, according to a study published June 4 in the Journal of the American College of Cardiology.
Jun 07, 2018 | Practice Management
Risk adjustment models for acute myocardial infarction (AMI) used by CMS suggest a diagnosis of atherosclerosis is associated with about a 40 percent reduction in 30-day mortality for Medicare beneficiaries. Researchers found hospitals that provide more extensive cardiac care are more likely to report the condition, thereby skewing the risk models.
Researchers have found the HeartMate 3 (HM3) left-ventricular assist device (LVAD) improves long-term outcomes and may also decrease the cost of care overtime for heart failure patients compared to the HeartMate II (HMII).
Acute kidney injury (AKI) occurs in about 9 percent of patients undergoing left atrial appendage closure (LAAC) and is associated with greater odds of downstream mortality and embolic events, according to a study published June 4 in JACC: Cardiovascular Interventions.
At just 5-months-old, Luke Pilkinton has survived what most would hope never to experience in a lifetime. He was born with hypoplastic left heart syndrome—a rare and deadly congenital defect, that affects 960 babies born in the U.S. every year.
Once more expensive P2Y12 inhibitors hit the U.S. market, the percentage of patients not filling prescriptions for any P2Y12 inhibitor after percutaneous coronary intervention (PCI) increased from 6 percent to 19 percent, researchers reported in JAMA Internal Medicine.
An investigational transcatheter mitral valve replacement (TMVR) device helped reduce mitral regurgitation to zero or trace levels in 98.7 percent of patients, according to 30-day follow-up data from the first 100 people scheduled to be treated with Abbott’s Tendyne system.
Assessment of coronary physiology to guide revascularization decisions has been linked to lower adverse event rates than using angiography alone, but the adoption of techniques such as fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) continues to lag behind guideline recommendations.
At EuroPCR in Paris, investigators of the controversial ORBITA trial presented two previously unreported benefits of percutaneous coronary intervention (PCI) for the study population.
Two hospitals in East Africa have announced participation in the American College of Cardiology’s CathPCI registry, which aims to assess treatments and outcomes related to cardiac catheterization and percutaneous coronary interventions (PCIs).
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) was associated with a 54 percent reduction in the composite endpoint of death, myocardial infarction and urgent revascularization when compared to medical therapy alone, according to five-year data from the FAME 2 trial.
Coronary Intervention & Surgery, Conferences
Saphenous vein graft (SVG) lesions can be treated just as well with bare metal stents (BMS) as drug-eluting stents (DES), suggests a double-blind, randomized trial published May 11 in The Lancet.
Coronary Intervention & Surgery
Left radial access (LRA) for percutaneous coronary intervention (PCI) remains rare in the United Kingdom, according to a registry analysis—but it is associated with similar clinical outcomes as right radial access (RRA) and possibly a reduced risk of stroke.
Coronary Intervention & Surgery
The investigators of the anticipated ISCHEMIA trial have published a paper in Circulation: Cardiovascular Quality and Outcomes defending their late addition of “softer” outcomes to their primary composite endpoint.
Coronary Intervention & Surgery, Acute Coronary Syndrome
Using data from the randomized COURAGE trial, a team of researchers developed a model to predict one-year angina and quality-of-life outcomes among patients with stable coronary artery disease (CAD).
Coronary Intervention & Surgery
Preliminary research presented May 11 at the American Heart Association’s Vascular Discovery: From Genes to Medicine Scientific Sessions 2018, suggests an injection may one day be able to reverse atherosclerosis.
Coronary Intervention & Surgery